An unnamed middleman in Mumbai provided a crucial raw material used in Indian-made cough syrups that have been linked to the deaths of more than 70 children in Gambia, a chemicals trader involved in the supply chain told Reuters.
The World Health Organization said last year the syrups, made by Indian manufacturer Maiden Pharmaceuticals Ltd, contained lethal toxins ethylene glycol and diethylene glycol – used in car brake fluid.
"I can't name the supplier - we have business links that we need to keep," said Goel, adding his company had "not done anything wrong." He said his business was "just a trader and we pass on sealed barrels that we get. We can do nothing with them." Asked to comment on the claim there was a middleman in the supply chain, the WHO's lead investigator said inquiries have reached a "dead end" due to a lack of information from the Indian authorities and the drugmaker.
India's regulator said its information on the raw materials came from certificates of analysis – standard paperwork used to track each ingredient in a drug supply chain. Maiden said last October that it had obtained raw materials from "certified and reputed companies."
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Deutsche Bank to cut 800 jobs after strong first quarter By Reuters⚠️BREAKING: *DEUTSCHE BANK SHARES JUMP AFTER POSTING 11TH STRAIGHT QUARTERLY PROFIT, REVEALS JOB CUTS $DB $DBK 🇩🇪🇩🇪
Read more »
Barclays beats profit expectations on credit card boom By Reuters⚠️BREAKING: *BARCLAYS BEATS Q1 PROFIT EXPECTATIONS ON CREDIT CARD BOOM; SHARES UP 4% $BARC $BCS 🇬🇧🇬🇧
Read more »
Red carpet style at the Time 100 Gala | Pictures | Reuters📸 From reuterspictures: Time Magazine held a gala celebrating its list of the 100 Most Influential People in the world in New York TIME100
Read more »
Amazon revenue beats on stable online demand, cloud strength By Reuters⚠️BREAKING: *AMAZON JUMPS 11% AFTER-HOURS FOLLOWING Q1 EARNINGS AND SALES BEAT $AMZN
Read more »
BVTV: Meta’s next act | Reuters VideoThe $530 billion company led by Mark Zuckerberg beat Wall Street’s expectations in its latest earnings report after a tough 2022. Its new AI plans look promising, but its metaverse bets are a costly distraction, explains Anita Ramaswamy.
Read more »